Nicky Ferdyan

Nicky Ferdyan is a Principal Scientist at Atomwise with extensive experience in drug discovery and pharmacokinetics. Previously, Nicky served as a Senior Scientist in DMPK at Turning Point Therapeutics, focusing on preclinical PK/PD studies, modeling, and ADME experiments. Nicky's career began at Ferring Pharmaceuticals, contributing to analytical chemistry and drug development through various roles, including Scientist and Sr Research Associate. Nicky's technical skills encompass metabolites identification, bioanalytical assay development, and pharmacokinetics prediction. Nicky holds a Bachelor of Science in Chemical Engineering from California State Polytechnic University-Pomona and is currently pursuing a Master of Science in Pharmacometrics at the University of Maryland, Baltimore.